Please Wait...

Slide

Topics

  • AGEING
  • ATRIAL FIBRILLATION AND HEART FAILURE
  • BIG DATA, PRECISION MEDICINE, ARTIFICIAL INTELLIGENCE, MACHINE LEARNING
  • BIOMARKERS
  • BLOOD PRESSURE MEASUREMENT
  • BLOOD PRESSURE TREATMENT THRESHOLDS AND TARGETS
  • BLOOD PRESSURE VARIABILITY
  • CARDIOVASCULAR ONCOLOGY
  • CARDIOVASCULAR RISK FACTORS
  • CEREBROVASCULAR DISEASES, COGNITIVE DYSFUNCTION AND DEMENTIA
  • CHILDREN AND ADOLESCENTS
  • CO-MORBIDITIES IN HYPERTENSION
  • CORONARY HEART DISEASE
  • COVID-19 AND CARDIOVASCULAR DISEASE
  • COVID-19 AND HYPERTENSION
  • DIABETES
  • ENDOCRINE HYPERTENSION
  • ENDOTHELIUM AND ATHEROSCLEROSIS
  • EPIDEMIOLOGY OF HYPERTENSION AND METABOLIC DISORDERS
  • ETHNIC ASPECTS
  • EXPERIMENTAL HYPERTENSION AND PHARMACOLOGY
  • GENETICS, GENOMICS, PROTEOMICS, METABOLOMICS
  • GLOBAL BURDEN OF HYPERTENSION ECONOMICAL ASPECTS
  • GLOBAL CVD PREVENTION
  • HEART AND HAEMODYNAMICS
  • HIGH ALTITUDE
  • HOME BP AMBULATORY
  • IMAGING IN HYPERTENSION
  • INFLAMMATION AND IMMUNITY
  • INTERVENTIONAL THERAPY AND DEVICES
  • KIDNEY
  • LARGE ARTERIES
  • LIFESTYLE CHANGES SALT DIETS LIPIDS
  • MICROCIRCULATION/SMALL VESSELS
  • NOCTURNAL BLOOD PRESSURE
  • OBESITY, SLEEP APNOEA AND METABOLIC SYNDROME
  • PREGNANCY
  • PRIMARY CARE/FAMILY MEDICINE
  • RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
  • RESISTANT HYPERTENSION
  • SPORT AND EXERCISE
  • STROKE
  • SYMPATHETIC NERVOUS SYSTEM AND OTHER NEURAL MECHANISMS
  • THERAPEUTICS AND CLINICAL TRIALS
  • TREATMENT ADHERENCE AND INERTIA THRESHHOLD AND TARGET IN HYPERTENSION